This topic contains a solution. Click here to go to the answer

Author Question: Consider the following anticholinergic medications, and select the one that a health care provider ... (Read 37 times)

Cooldude101

  • Hero Member
  • *****
  • Posts: 557
Consider the following anticholinergic medications, and select the one that a health care provider working in a preoperative holding unit would anticipate administering to a newly admitted pa-tient.
 
  a. Dicyclomine (Bentyl)
  b. Clidinium (Quarzan)
  c. Glycopyrrolate (Robinul)
  d. Propantheline (Pro-Banthine)

Question 2

A patient has a history of liver disease. Which of the following neuromuscular blocking agents will this patient best tolerate?
 
  a. Pancuronium (Pavulon)
  b. Vecuronium (Norcuron)
  c. Mivacurium (Mivacron)
  d. Atracurium (Tracrium)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

macagn

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

ANS: C
Glycopyrrolate is used as a preoperative agent to inhibit salivation and excessive respiratory se-cretions.

Answer to Question 2

ANS: D
The organ-independent biotransformation of atracurium makes it attractive for patients with mul-tiple organ system failure.




Cooldude101

  • Member
  • Posts: 557
Reply 2 on: Jul 23, 2018
Thanks for the timely response, appreciate it


irishcancer18

  • Member
  • Posts: 310
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Excessive alcohol use costs the country approximately $235 billion every year.

For a complete list of videos, visit our video library